What's more, it addresses the FDA’s communications with the applicant, the retention of data that help the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may possibly transfer ownership of the SE report to a different applicant and Digital submission in the SE report and amendment